Photo of Katie J. Suda

Katie J. Suda


Associate Professor, Pharmacy Systems, Outcomes and Policy
Center Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research

Contact

Building & Room:

Room 227, College of Pharmacy

Address:

833 S. Wood Street, Chicago, IL, 60612

Office Phone:

(312) 355-5148

Email:

ksuda@uic.edu

About

Research Interests: Dr. Katie Suda is a Research Health Scientist with the Center of Innovation for Complex Chronic Healthcare at the Department of Veterans Affairs (VA) and an Associate Professor in the Department of Pharmacy Systems, Outcomes, and Policy. Dr. Suda received a Doctor of Pharmacy from Drake University in 1999 and a M.S. in epidemiology from the University of Tennessee Health Science Center. She completed a pharmacy practice residency at Baptist Memorial Health Care in Memphis, Tennessee and infectious diseases and outcomes research fellowship at UIC. Dr. Suda’s area of research is pharmacoepidemiology, especially in the area of antimicrobials, and dual use of VA and non-VA health care. Dr. Suda joined CPR in 2014.

Clinical Interests: clinical pharmacy, infectious diseases, antimicrobial stewardship

Selected Publications

  • Fitzpatrick MA, Suda K, Ramanathan S, Guihan M, Brown C, Safdar N, Evans M, Jones MM, Pfeiffer CD, Klutts JS, Icardi M, Perencevich E, Rubin M, Evans CT. “Laboratory practices for identification and reporting of carbapenem-resistant Enterobacteriaceae in Department of Veterans Affairs facilities”. Infection Control and Hospital Epidemiology. 2019;40(4):463-466. doi:10.1017/ice.2019.24.
  • Skelton F, Suda K, Evans C, Trautner B. “Effective antibiotic stewardship in spinal cord injury: Challenges and a way forward”. Journal of Spinal Cord Medicine. 2019;42(2):251-254. doi:10.1080/10790268.2017.1396183.
  • Fitzpatrick MA, Suda K, Burns SP, Poggensee L, Ramanathan S, Evans CT. “Pre-operative screening for asymptomatic bacteriuria and associations with post-operative outcomes in patients with spinal cord injury”. Journal of Spinal Cord Medicine. 2019;42(2):255-259. doi:10.1080/10790268.2018.1451237.
  • Fitzpatrick MA, Suda K, Jones MM, Burns SP, Poggensee L, Ramanathan S, Evans M, Evans CT. “Effect of varying federal definitions on prevalence and characteristics associated with carbapenem-resistant Enterobacteriaceae in veterans with spinal cord injury”. American Journal of Infection Control. 2019;47(2):175-179. doi:10.1016/j.ajic.2018.08.001.
  • Radomski TR, Zhao X, Hanlon JT, Thorpe JM, Thorpe CT, Naples JG, Sileanu FE, Cashy JP, Hale JA, Mor MK, Hausmann LR, Donohue JM, Suda K, Stroupe KT, Good CB, Fine MJ, Gellad WF. “Use of a medication-based risk adjustment index to predict mortality among veterans dually-enrolled in VA and medicare”. Healthcare. 2019;. doi:10.1016/j.hjdsi.2019.04.003.
  • Carico R, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LR, Donohue JM, Suda K, Stroupe K, Hanlon JT, Good CB, Fine MJ, Gellad WF. “Receipt of overlapping opioid and benzodiazepine prescriptions among veterans dually enrolled in Medicare Part D and the Department of Veterans Affairs: A cross-sectional study”. Annals of Internal Medicine. 2018;169(9):593-601. doi:10.7326/M18-0852.
  • Dumkow LE, Axford KL, Suda K, Draper HM, Brandt KL. “Impact of a stewardship-focused culture follow-up initiative on the treatment of pharyngitis in the emergency department and urgent care settings”. Diagnostic Microbiology and Infectious Disease. 2018;92(2):136-142. doi:10.1016/j.diagmicrobio.2018.05.014.
  • Radomski TR, Bixler FR, Zickmund SL, Roman KL, Thorpe CT, Hale JA, Sileanu FE, Hausmann LR, Thorpe JM, Suda K, Stroupe KT, Gordon AJ, Good CB, Fine MJ, Gellad WF. “Physicians’ Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study”. Journal of General Internal Medicine. 2018;33(8):1253-1259. doi:10.1007/s11606-018-4374-1.
  • Schumock GT, Stubbings JA, Wiest MD, Li EC, Suda K, Matusiak LM, Hunkler RJ, Vermeulen LC. “National trends in prescription drug expenditures and projections for 2018”. American Journal of Health-System Pharmacy. 2018;75(14):1023-1038. doi:10.2146/ajhp180138.
  • Ramanathan S, Suda K, Fitzpatrick MA, Poggensee L, LaVela SL, Burns SP, Evans CT. (2018). “Response to letter on “Multidrug-resistant Acinetobacter: Risk factors and outcome in veterans with spinal cord injuries and disorders””. American Journal of Infection Control. Vol. 46. Issue 7. Page(s) 849. https://api.elsevier.com/content/abstract/scopus_id/85048883200
  • Hatch MN, Raad J, Suda K, Stroupe KT, Hon AJ, Smith BM. “Evaluating the Use of Medicare Part D in the Veteran Population With Spinal Cord Injury/Disorder”. Archives of Physical Medicine and Rehabilitation. 2018;99(6):1099-1107. doi:10.1016/j.apmr.2017.12.036.
  • Markossian TW, Suda K, Abderhalden L, Huo Z, Smith BM, Stroupe KT. “Characteristics and medication use of veterans in medicare advantage plans”. American Journal of Managed Care. 2018;24(5):247-255.
  • Dana R, Azarpazhooh A, Laghapour N, Suda K, Okunseri C. (2018). “Role of Dentists in Prescribing Opioid Analgesics and Antibiotics: An Overview”. Dental Clinics of North America. Vol. 62. Issue 2. Page(s) 279-294. https://api.elsevier.com/content/abstract/scopus_id/85042799192
  • Lee WJ, Lee TA, Calip GS, Suda K, Briars LA, Schumock GT. “Risk of Serious Bacterial Infection Associated with Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease”. Inflammatory Bowel Diseases. 2018;24(4):883-891. doi:10.1093/ibd/izx080.
  • Fitzpatrick MA, Suda K, Safdar N, Burns SP, Jones MM, Poggensee L, Ramanathan S, Evans CT. “Changes in bacterial epidemiology and antibiotic resistance among veterans with spinal cord injury/disorder over the past 9 years”. Journal of Spinal Cord Medicine. 2018;41(2):199-207. doi:10.1080/10790268.2017.1281373.
  • Gellad WF, Thorpe JM, Zhao X, Thorpe CT, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LR, Donohue JM, Gordon AJ, Suda K, Stroupe KT, Hanlon JT, Cunningham FE, Good CB, Fine MJ. “Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid Use”. American Journal of Public Health. 2018;108(2):248-255. doi:10.2105/AJPH.2017.304174.
  • Suda K, Livorsi DJ, Goto M, Forrest GN, Jones MM, Neuhauser MM, Hoff BM, Ince D, Carrel M, Nair R, Knobloch MJ, Goetz MB. (2018). “Research Agenda for Antimicrobial Stewardship in the Veterans Health Administration”. Infection Control and Hospital Epidemiology. Vol. 39. Issue 2. Page(s) 196-201. https://api.elsevier.com/content/abstract/scopus_id/85044308746
  • Lee WJ, Lee TA, Suda K, Calip GS, Briars LA, Schumock GT. “Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis”. Rheumatology (United Kingdom). 2018;57(2):273-282. doi:10.1093/rheumatology/kex049.
  • Livorsi DJ, Evans CT, Morgan DJ, Reisinger HS, Safdar N, Suda K, Perencevich EN. (2018). “Setting the Research Agenda for Preventing Infections from Multidrug-Resistant Organisms in the Veterans Health Administration”. Infection Control and Hospital Epidemiology. Vol. 39. Issue 2. Page(s) 186-188. https://api.elsevier.com/content/abstract/scopus_id/85044292028
  • Evans CT, Fitzpatrick MA, Jones MM, Burns SP, Poggensee L, Ramanathan S, LaVela SL, Safdar N, Suda K. “Prevalence and Factors Associated with Multidrug-Resistant Gram-Negative Organisms in Patients with Spinal Cord Injury”. Infection Control and Hospital Epidemiology. 2017;38(12):1464-1471. doi:10.1017/ice.2017.238.
  • Ramanathan S, Suda K, Fitzpatrick MA, Poggensee L, LaVela SL, Burns SP, Evans CT. “Multidrug-resistant Acinetobacter: Risk factors and outcomes in veterans with spinal cord injuries and disorders”. American Journal of Infection Control. 2017;45(11):1183-1189. doi:10.1016/j.ajic.2017.06.016.
  • Kim EY, Patel U, Patel B, Suda K. “Evaluation of Bacteriuria Treatment and Follow-up Initiated in the Emergency Department at a Veterans Affairs Hospital”. Journal of Pharmacy Technology. 2017;33(5):183-188. doi:10.1177/8755122517718214.
  • Schumock GT, Li EC, Wiest MD, Suda K, Stubbings J, Matusiak LM, Hunkler RJ, Vermeulen LC. “National trends in prescription drug expenditures and projections for 2017”. American Journal of Health-System Pharmacy. 2017;74(15):1158-1173. doi:10.2146/ajhp170164.
  • Fitzpatrick MA, Suda K, Evans CT, Hunkler RJ, Weaver F, Schumock GT. (2017). “Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005-15”. American Journal of Health-System Pharmacy. Vol. 74. Issue 14. Page(s) 1076-1083. https://api.elsevier.com/content/abstract/scopus_id/85024392214
  • Kale IO, Fitzpatrick MA, Suda K, Burns SP, Poggensee L, Ramanathan S, Sabzwari R, Evans CT. “Risk factors for community-associated multidrug-resistant Pseudomonas aeruginosa in veterans with spinal cord injury and disorder: A retrospective cohort study”. Spinal Cord. 2017;55(7):687-691. doi:10.1038/sc.2017.7.
  • Stroupe KT, Bailey L, Gellad WF, Suda K, Huo Z, Martinez R, Burk M, Cunningham F, Smith BM. “Veterans’ Pharmacy and Health Care Utilization Following Implementation of the Medicare Part D Pharmacy Benefit”. Medical Care Research and Review. 2017;74(3):328-344. doi:10.1177/1077558716643887.
  • Luepke KH, Suda K, Boucher H, Russo RL, Bonney MW, Hunt TD, Mohr JF. “Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications”. Pharmacotherapy. 2017;37(1):71-84. doi:10.1002/phar.1868.
  • Lee WJ, Briars LA, Lee TA, Calip GS, Suda K, Schumock GT. “Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis”. Pharmacotherapy. 2016;36(12):1201-1209. doi:10.1002/phar.1856.
  • Suda K, Patel UC, Sabzwari R, Cao L, Ramanathan S, Hill JN, Evans CT. “Bacterial susceptibility patterns in patients with spinal cord injury and disorder (SCI/D): An opportunity for customized stewardship tools”. Spinal Cord. 2016;54(11):1001-1009. doi:10.1038/sc.2016.38.
  • Lee WJ, Briars LA, Lee TA, Calip GS, Suda K, Schumock GT. “Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease”. Inflammatory Bowel Diseases. 2016;22(10):2410-2417. doi:10.1097/MIB.0000000000000880.
  • Schumock GT, Li EC, Suda K, Wiest MD, Stubbings JA, Matusiak LM, Hunkler RJ, Vermeulen LC. “National trends in prescription drug expenditures and projections for 2016”. American Journal of Health-System Pharmacy. 2016;73(14):1058-1075. doi:10.2146/ajhp160205.
  • Spencer S, Suda K, Smith BM, Huo Z, Bailey L, Stroupe KT. “Erectile dysfunction medication use in veterans eligible for medicare part D”. Journal of Managed Care and Specialty Pharmacy. 2016;22(7):818-824. doi:10.18553/jmcp.2016.22.7.818.
  • Fitzpatrick MA, Suda K, Safdar N, Goldstein B, Jones MM, Poggensee L, Ramanathan S, Lewan R, Evans CT. “Unique Risks and Clinical Outcomes Associated with Extended-Spectrum β-Lactamase Enterobacteriaceae in Veterans with Spinal Cord Injury or Disorder: A Case-Case-Control Study”. Infection Control and Hospital Epidemiology. 2016;37(7):768-776. doi:10.1017/ice.2016.60.
  • Hamilton LA, Franks A, Heidel RE, McDonough SL, Suda K. “Assessing the value of online learning and social media in pharmacy education”. American Journal of Pharmaceutical Education. 2016;80(6).
  • Hill JN, Suda K, Ramanathan S, Evans CT. “Development of a unit-specific antibiogram and planning for implementation: Preimplementation findings”. American Journal of Infection Control. 2015;43(11):1264-1267. doi:10.1016/j.ajic.2015.06.020.
  • Hartke P, Vermeulen LC, Hoffman JM, Shah ND, Doloresco F, Suda K, Li EC, Matusiak LM, Hunkler RJ, Schumock GT. “Accuracy of annual prescription drug expenditure forecasts in AJHP”. American Journal of Health-System Pharmacy. 2015;72(19):1642-1648. doi:10.2146/ajhp140850.
  • Schumock GT, Li EC, Suda K, Wiest MD, Stubbings J, Matusiak LM, Hunkler RJ, Vermeulen LC. National trends in prescription drug expenditures and projections for 2015.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2015;72(9):717-36. doi:10.2146/ajhp140849.
  • Touchette D, Doloresco F, Suda KC, Perez AM, Turner S, Tangonan M, Hoffman J. Economic evaluations of clinical pharmacy services: 2006-2010.. Pharmacotherapy. 2014;34(8):771-93. doi:10.1002/phar.1414.
  • Schumock GT, Li EC, Suda K, Matusiak LM, Hunkler RJ, Vermeulen LC, Hoffman JM. National trends in prescription drug expenditures and projections for 2014.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014;71(6):482-99. doi:10.2146/ajhp130767.
  • Suda K, Regen SM, Lee TA, Easterling JL, Hunkler RJ, Danziger LH. Outpatient influenza antiviral prescription trends with influenza-like illness in the USA, 2008-2010.. International journal of antimicrobial agents. 2014;43(3):279-83. doi:10.1016/j.ijantimicag.2013.10.025.
  • Suda K, Hicks LA, Roberts RM, Hunkler RJ, Danziger LH. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009.. The Journal of antimicrobial chemotherapy. 2013;68(3):715-8. doi:10.1093/jac/dks445.
  • Suda K, Garey KW, Danziger LH. Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone.. Pharmacy world & science : PWS. 2005;27(2):81-2.